COMP <GO>
THRM vs PG // EV/EBITDA & P/E VALUATION
Gentherm Inc (NASDAQ) VS. Procter & Gamble Company (NYSE) • 15-METRIC TALLY: THRM 2
— PG 9
▲ EV/EBITDA & P/E VALUATION LEADER: THRM
LAST: $30.95 (-3.88%) • MKT CAP: $1.69B
valuation
13.2x
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
valuation
16.2x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (THRM VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | THRM | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 24.20% | 51.20% | -27.00 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.70% | 25.40% | -16.70 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 13.2x | 16.2x | -3.00 | THRM | /valuation <GO> |
| Free Cash Flow Yield | 3.62% | 3.77% | -0.15 | PG | /fcf-yield <GO> |
| Operating Margin | 5.50% | 24.30% | -18.80 | PG | /operating-margins <GO> |
| Net Profit Margin | — | 19.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 2.90% | 0.30% | +2.60 | THRM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.81 | 5.59 | -1.78 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | PG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.0 | 60.3 | -8.30 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.87 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 21.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.69B | $372.21B | -$370.52B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | THRM REV | PG REV | THRM GROSS % | PG GROSS % | THRM FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.50B | $84.28B | 24.2% | 51.2% | $61.1M | $14.04B |
| FY 2024 | $1.46B | $84.04B | 25.2% | 51.4% | $36.3M | $16.52B |
| FY 2023 | $1.47B | $82.01B | — | — | $119.3M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
THRM // BETA —
PG // BETA 0.87